World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00370799
Date of registration: 30/08/2006
Prospective Registration: Yes
Primary sponsor: Pain Management Center of Paducah
Public title: Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain
Scientific title: A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Caudal Epidural Injections in Lumbar Disc Herniations, Spinal Stenosis, Discogenic Pain, and Post-Lumbar Laminectomy Syndrome
Date of first enrolment: January 2007
Target sample size: 240
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00370799
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment  
Phase:  Phase 0
Countries of recruitment
United States
Contacts
Name:     Laxmaiah Manchikanti, MD
Address: 
Telephone:
Email:
Affiliation:  Ambulatory Surgery Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- At least 18 years of age

- History of chronic, function-limiting low back pain of at least 6 months duration

- Able to give voluntary, written informed consent to participate,

- Able to understand the investigation, cooperate with the procedures, and willing to
return for follow-up

- No recent surgical procedures within last three months

Exclusion Criteria:

- Cauda Equina symptoms and/or compressive radiculopathy

- Narcotic use of no greater than 100mg/day hydrocodone, 60mg Methadone. or 100mg
morphine

- Uncontrolled major Depression or uncontrolled psychiatric disorder

- Uncontrolled or acute medical illnesses

- Chronic severe conditions that could interfere with outcome assessments

- Women who are pregnant or lactating

- Subjects who have participated in a clinical study with an investigational product
within 30 days of enrollment

- Patients with multiple complaints involving concomitant hip osteoarthritis

- Inability to achieve proper positioning and inability to understand informed consent
and protocol

- History of adverse reaction to local anesthetic or anti-inflammatory drugs and
history of gastrointestinal bleeding or ulcers



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Low Back Pain
Intervention(s)
Drug: Caudal epidural injection
Drug: Caudal Epidural Injection with Celestone
Drug: Caudal Epidural Injection with DepoMedrol
Drug: Caudal Epidural Injection with generic Celestone
Primary Outcome(s)
To evaluate for differences between the patients in various groups in the physical function and pain at 1, 3, 6, and 12 months post treatment [Time Frame: 1,3,6,12 months]
Secondary Outcome(s)
To assess adverse events in all four groups. [Time Frame: 1,3,6,12 months]
Secondary ID(s)
protocol 10
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history